|Bid||10.20 x 900|
|Ask||10.35 x 800|
|Day's Range||10.20 - 10.40|
|52 Week Range||9.85 - 19.80|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
VG Acquisition Corp. (NYSE: VGAC), a special purpose acquisition company sponsored by Virgin Group, today announced that it has filed an amended registration statement on Form S-4 in connection with its pending business combination with 23andMe, Inc., a leading consumer genetics and research company.
Every investor in VG Acquisition Corp. ( NYSE:VGAC ) should be aware of the most powerful shareholder groups...
Here's why long-term investors might want to take a look at this genetics company before it's officially public.